参考文献
|
-
http://www.cancer.net/navigating-cancer-care/side-effects/hand-foot-syndrome-or-palmar-plantar-erythrodysesthesia.
-
http://www.kfsyscc.org/about/interview-topics/yao-wu-ba-shou-jiao-ran-gong-le--.
-
Assi, Hussein A.,Ayoub, Zeina A.,Jaber, Sara M.,Sibai, Hassan A.,El Saghir, Nagi S.(2013).Management of Paclitaxel-Induced Hand-Foot Syndrome.Breast Care,8,215-217.
-
Braik, T,Yim, B,Evans, AT,Kassem, M,Mullane, M,Lad, T,Hussein, L,Cleveland, B,McDunn, S(2014).Randomized trial of vitamin B6 for preventing hand-foot syndrome from capecitabine chemotherapy.J Community Support Oncol,12(2),65-70.
-
Drake, RD,Lin, WM,King, M(2004).Oral dexamethasone attenuates Doxil®-induced palmar-plantar erythrodysesthesias in patients with recurrent gynecologic malignancies.Gynecol Oncol,94,320-324.
-
Janusch, M,Fischer, M,Marsch, Wch(2006).The hand-foot syndrome– a frequent secondary manifestation in antineoplastic chemotherapy.Eur J Dermatol,16(5),494-499.
-
Kollmannsberger, C,Mayer, F,Harstrick, A(2000).Reduction of skin toxicity of pegylated liposomal doxorubicin(PLD) by concomitant administration of dexamethasone and pyridoxine in patients(pts) with anthracyclin-sensitive malignancies- a phase I/II trial. 25th Congress of the European Society of Medical Oncology.Ann Oncol,11(Suppl4),136.
-
Levine, LE,Medenica, MM,Lorincz, AL(1985).Distinctive acral erythema occurring during therapy for severe myelogenous leukemia.Arch Dermatol,121,102.
-
Lin, Morris JS,Ayers, GD(2002).Effect of celecoxib on capecitabine-indiced hand-foot syndrome and antitumor activity.Oncology,16,31-37.
-
Lipworth, AD,Robert, C,Zhu, AX(2009).Hand-foot syndrome (hand-foot skin reaction, palmar-plantar erythrodysesthesia): focus on sorafenib and sunitinib.Oncology,77,257-271.
-
Nagore, E,Insa, A,Sanmartı’n, O(2000).Antineoplastic Therapy-Induced Palmar Plantar Erythrodysesthesia (’Hand-Foot’) Syndrome: Incidence, Recognition and Management.American Journal of Clinical Dermatology,1,225-234.
-
Aimee S Payne, Diane MF Savarese:Cutaneous complications of conventional chemotherapy agents,UpToDate,2015。
-
Porta, C,Paglino, C,Imarisio, I(2007).Uncovering Pandora’s vase: the growing problem of new toxicities from novel anticancer agents: the case of sorafenib and sunitinib.Clin Exp Med,7,127-134.
-
Ren, Z,Zhu, K,Kang, H(2015).Randomized controlled trial of the prophylactic effect of urea-based cream on sorafenib-associated hand-foot skin reactions in patients with advanced hepatocellular carcinoma.J Clin Oncol,33,894.
-
Saif, MW,Elfiky, A,Diasio, R(2006).Hand-foot syndrome variant in a dihydropyrimidine dehydrogenase-deficient patient treated with capecitabine.Clin Colorectal Cancer,6(3),219-223.
-
Tsuboi, H,Yonemoto, K,Katsuoka, K(2005).A case of bleomycin-induced acral erythema (AE) with eccrine squamous syringometaplasia (ESS) and summary of reports of AE with ESS in the literature.J Dermatol,32,921.
-
李姿慧,蔡榮林,王鍵(2007)。針藥結合治療痺證優勢探討。遼寧中醫學大學學報,9(5),64-65。
-
李耀泰,陳福民,何民康,鄭文雄,陳天惠,郭宗正(2008)。掌蹠紅斑觸痛徵候群。中華民國婦癌醫學雜誌,2,17-23。
-
周勝漣,陳州華,龔輝(2013)。化療後手足綜合征的中西醫治療研究進展。中西醫結合研究,5(1),38-40。
-
林昭庚.新編彩圖針灸學.知音出版社.
-
姜宏睿,楊國良(1999)。針刺加灸法治療風寒濕痺證。針灸臨床雜誌,15(2),14。
-
張若燕,李利亞,呂清臨(2007)。加味黃耆桂枝五物湯防治希羅達相關性手足綜合徵的臨床觀察。遼寧中醫雜誌,34(6),783-784。
-
許昇峰(2001).針灸臨床指引.台灣:衛生署中醫藥委員會.
-
郭中寧,楊宇飛(2005)。中藥護胃癒膚湯治療希羅達相關性手足綜合徵 33 例。中國腫瘤,14(9),625-627。
-
郭楊,郭勇(2014)。中藥泡腳方治療卡培他濱相關性手足綜合征 21 例療效觀察。福建中醫藥大學學報,24(5),59-60。
-
陳州華,周勝漣(2012)。芪歸通絡湯浸泡治療化療後手足綜合征 30 例。陝西中醫,33(1),32-33。
-
陳榮洲.中醫內科證治學.弘祥出版社.
-
趙江寧,關瑞劍,李紅毅(2009)。中藥治療卡培他濱相關性手足綜合徵臨床觀察。新中醫,41(8),59-61。
-
趙京生(2012)。針灸治療理論建設探討─以針灸治痺為例。北京中醫藥大學學報(中醫臨床版),19(5),7-11。
-
趙欲曉(2009)。淺談《內經》中有關痺證的針灸治療。針灸臨床雜誌,25(11),45-46。
-
韓毛毛,陳國英(2014)。中藥熏洗治療化療相關性手足綜合征 30 例觀察。浙江中醫雜誌,49(9),661-662。
-
嚴興科,高洋,楊波(2008)。《內經》論痺分型及針灸辨證特點探討。遼寧中醫藥大學學報,10(7),7-8。
|